Hydrochloric Acid

Hydrochloric Acid

SCHEMBL784866

Cl.O=C(O)c1ccccc1Cl

nearest known ligand 0.95

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 known ✓ P00918 1/20 0.52
HDAC8 known ✓ Q9BY41 1/20 0.50
TTR known ✓ P02766 1/20 0.50
HTR1A known ✓ P08908 1/20 0.50
ADRA2A known ✓ P08913 1/20 0.50
HTR2A known ✓ P28223 1/20 0.50
ADRA1A known ✓ P35348 1/20 0.50
PTGS2 known ✓ P35354 1/20 0.50
ALDH1A1 P00352 4/20 0.95
CES2 O00748 1/20 0.65
CES1 P23141 1/20 0.65
TSHR P16473 2/20 0.64
ALOX15 P16050 1/20 0.62
POLB P06746 2/20 0.58
ERCC5 P28715 1/20 0.53
FEN1 P39748 1/20 0.53
HPGD P15428 3/20 0.52
SMN1; SMN2 Q16637 2/20 0.52
KDM4E B2RXH2 2/20 0.52
CA12 O43570 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29518925 0.97 ALDH1A1 (1.00) ALDH1A1CES2CES1TSHRALOX15
SCHEMBL29369803 0.97 ALDH1A1 (1.00) ALDH1A1CES2CES1TSHRALOX15
SCHEMBL29004189 0.97 ALDH1A1 (1.00) ALDH1A1CES2CES1TSHRALOX15
SCHEMBL367 0.97 ALDH1A1 (1.00) ALDH1A1CES2CES1TSHRALOX15
SCHEMBL8482425 0.97 ALDH1A1 (1.00) ALDH1A1CES2CES1TSHRALOX15
Hydrochloric Acid SCHEMBL28198869 0.95 ALDH1A1 (0.86) ALDH1A1CES2CES1TSHRALOX15
SCHEMBL11768054 0.95 ALDH1A1 (0.95) ALDH1A1CES2CES1TSHRALOX15
SCHEMBL6915337 0.95 ALDH1A1 (0.95) ALDH1A1CES2CES1TSHRALOX15
SCHEMBL8612015 0.95 ALDH1A1 (0.95) ALDH1A1CES2CES1TSHRALOX15
Fluoride SCHEMBL6444932 0.95 ALDH1A1 (0.95) ALDH1A1CES2CES1TSHRALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 70 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210292264-A1 Process for Manufacture of Fluorinated Benzenes and Fluorinated Benzophenones, and Derivatives Thereof FUJIAN YONGJING TECHNOLOGY CO., LTD (CN) 2021-09-23 US claimed
EP-3713907-A1 NEW PROCESS FOR MANUFACTURE OF FLUORINATED BENZENES AND FLUORINATED BENZOPHENONES, AND DERIVATIVES THEREOF Fujian Yongjing Technology Co., Ltd (CN) 2020-09-30 EP claimed
US-20200262776-A1 New Process for the Manufacture of Fluorinated Benzenes and Fluorinated Benzophenones, and Derivatives Thereof FUJIAN YONGJING TECHNOLOGY CO., LTD (CN) 2020-08-20 US claimed
WO-2020164291-A1 NEW PROCESS FOR MANUFACTURE OF FLUORINATED BENZENES AND FLUORINATED BENZOPHENONES, AND DERIVATIVES THEREOF FUJIAN YONGJING TECHNOLOGY CO., LTD (CN) 2020-08-20 WO claimed
US-20240208992-A1 MACROCYCLES AS CFTR MODULATORS IDORSIA PHARMACEUTICALS LTD (CH) 2024-06-27 US disclosed
US-11465958-B2 Process for Friedel-Crafts reaction, and catalyst therefore FUJIAN YONGJING TECHNOLOGY CO., LTD. (CN) 2022-10-11 US disclosed
US-20210292264-A1 Process for Manufacture of Fluorinated Benzenes and Fluorinated Benzophenones, and Derivatives Thereof FUJIAN YONGJING TECHNOLOGY CO., LTD (CN) 2021-09-23 US disclosed
CN-108430997-B Microbicidal oxadiazole derivatives 先正达参股股份有限公司 2021-06-04 CN disclosed
US-11008273-B2 Process for the manufacture of fluorinated benzenes and fluorinated benzophenones, and derivatives thereof FUJIAN YONGJING TECHNOLOGY CO., LTD (CN) 2021-05-18 US disclosed
US-20200262776-A1 New Process for the Manufacture of Fluorinated Benzenes and Fluorinated Benzophenones, and Derivatives Thereof FUJIAN YONGJING TECHNOLOGY CO., LTD (CN) 2020-08-20 US disclosed
US-20200262775-A1 Process for Friedel-Crafts Reaction, and Catalyst Therefore FUJIAN YONGJING TECHNOLOGY CO., LTD. (CN) 2020-08-20 US disclosed
WO-2020164218-A1 NEW PROCESS FOR FRIEDEL-CRAFTS REACTION, AND CATALYST THEREFORE FUJIAN YONGJING TECHNOLOGY CO., LTD (CN) 2020-08-20 WO disclosed
US-4480030-A BLOOD-COAGULATION FACTOR XA PENTAPHARM A.G. (CH) 1984-10-30 US disclosed
US-4440678-A ARGININES PENTAPHARM, A.G. (CH) 1984-04-03 US disclosed
EP-0051828-B1 N-BENZOYL-ALPHA-ANILINO ALKANE CARBOXYLIC ACIDS, SALTS AND ESTERS THEREOF, PROCESS FOR PRODUCING THE SAME AND PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME A. Nattermann & Cie. GmbH (DE) 1984-03-14 EP disclosed
US-4388246-A THERMAL SPLITTING OF CARBAMATES BAYER AKTIENGESELLSCHAFT (DE) 1983-06-14 US disclosed
US-4386031-A ANTICOAGULANTS; ANTIALLERGENS; ANTINFLAM-MATORY AND ANTILIPEMIC AGENTS; ANTIHISTAMINES; CARDIOVASCULAR DISORDERS A. NATTERMANN & CIE GMBH (DE) 1983-05-31 US disclosed
EP-0051828-A1 N-benzoyl-alpha-anilino alkane carboxylic acids, salts and esters thereof, process for producing the same and pharmaceutical preparations containing the same A. Nattermann & Cie. GmbH (DE) 1982-05-19 EP disclosed
US-4179436-A DYEING POLYESTERS BAYER AKTIENGESELLSCHAFT (DE) 1979-12-18 US disclosed
US-4065458-A VASODILATORS RICHTER GEDEON VEGYESZETI GYAR RT. (HU) 1977-12-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11008273-B2 Process for the manufacture of fluorinated benzenes and fluorinated benzophenones, and derivatives thereof PFAS, PFKFB4, PFKFB2 CA2 4673/4885HDAC8 3606/4885TTR 4282/4885
US-11465958-B2 Process for Friedel-Crafts reaction, and catalyst therefore HNF4A, TFEB, HACL2 CA2 2745/4885HDAC8 2531/4885TTR 1669/4885
US-20200262776-A1 New Process for the Manufacture of Fluorinated Benzenes and Fluorinated Benzophenones, and Derivatives Thereof PFAS, PFKFB4, PFKFB1 CA2 4778/4885HDAC8 3609/4885TTR 4348/4885
US-20210292264-A1 Process for Manufacture of Fluorinated Benzenes and Fluorinated Benzophenones, and Derivatives Thereof PFAS, PFKFB4, PFKFB2 CA2 4757/4885HDAC8 3577/4885TTR 4250/4885
US-20240208992-A1 MACROCYCLES AS CFTR MODULATORS CFTR, PKD1, ARRB1 CA2 2641/4885HDAC8 3279/4885TTR 3696/4885
US-20200262775-A1 Process for Friedel-Crafts Reaction, and Catalyst Therefore HNF4A, TFEB, HACL2 CA2 2745/4885HDAC8 2531/4885TTR 1669/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.